Raha Samraat S., President and CEO of Myriad Genetics Inc. ($MYGN), made one open market purchase of common shares in the last 365 days, totaling $199,844. His most recent buy occurred on March 9, 2026. This purchase ranks 1,583rd out of 4,983 individual insiders, below the average of $1.46 million per buyer and 3.3 transactions. Raha Samraat S. reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | President and CEO | A | Common Stock | 618557 | $0.00 | 1,111,661.0000 | 93,213,722 | 125.44% | 0.66% |
| March 13, 2026 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | President and CEO | F | Common Stock | 36304 | $4.66 | 1,075,357.0000 | 93,213,722 | 3.27% | 0.04% |
| March 14, 2026 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | President and CEO | F | Common Stock | 10816 | $4.66 | 1,064,541.0000 | 93,213,722 | 1.01% | 0.01% |
| March 9, 2026 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | President and CEO | P | Common Stock | 40000 | $5.00 | 493,104.0000 | 93,213,722 | 8.83% | 0.04% |
| Dec. 11, 2025 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | President and CEO | F | Common Stock | 29634 | $7.30 | 453,104.0000 | 93,213,722 | 6.14% | 0.03% |
| May 31, 2025 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | President and CEO | A | Common Stock | 1498 | $3.56 | 482,738.0000 | 91,309,064 | 0.31% | 0.00% |
| April 30, 2025 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | President and CEO | A | Performance-Based Restricted Stock Units | 141050 | $0.00 | 141,050.0000 | 91,309,064 | 9999.99% | 0.15% |
| March 14, 2025 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | Chief Operating Officer | F | Common Stock | 7649 | $10.07 | 481,240.0000 | 91,309,064 | 1.56% | 0.01% |
| March 13, 2025 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | Chief Operating Officer | A | Common Stock | 216495 | $0.00 | 488,889.0000 | 91,309,064 | 79.48% | 0.24% |
| Dec. 11, 2024 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | Chief Operating Officer | F | Common Stock | 29578 | $14.51 | 272,394.0000 | 0 | 9.79% | 0.00% |
| Nov. 30, 2024 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | Chief Operating Officer | A | Common Stock | 1118 | $13.83 | 301,972.0000 | 0 | 0.37% | 0.00% |
| March 14, 2024 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | Chief Operating Officer | A | Common Stock | 64494 | $0.00 | 300,854.0000 | 0 | 27.29% | 0.00% |
| Dec. 11, 2023 | MYRIAD GENETICS INC | $MYGN | Raha Samraat S. | Chief Operating Officer | A | Common Stock | 236360 | $0.00 | 236,360.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2023 | AGILENT TECHNOLOGIES, INC. | $A | Raha Samraat S. | Sr. Vice President | F | Common Stock | 3434 | $111.61 | 87,195.6096 | 296,000,000 | 3.79% | 0.00% |
| Nov. 14, 2023 | AGILENT TECHNOLOGIES, INC. | $A | Raha Samraat S. | Sr. Vice President | A | Common Stock | 11225 | $111.61 | 90,629.6096 | 296,000,000 | 14.14% | 0.00% |
| Nov. 16, 2023 | AGILENT TECHNOLOGIES, INC. | $A | Raha Samraat S. | Sr. Vice President | F | Common Stock | 345 | $114.19 | 86,685.6096 | 296,000,000 | 0.40% | 0.00% |
| Nov. 17, 2023 | AGILENT TECHNOLOGIES, INC. | $A | Raha Samraat S. | Sr. Vice President | F | Common Stock | 1578 | $113.15 | 85,107.6096 | 296,000,000 | 1.82% | 0.00% |
| Nov. 14, 2023 | AGILENT TECHNOLOGIES, INC. | $A | Raha Samraat S. | Sr. Vice President | F | Common Stock | 3171 | $111.61 | 87,458.6096 | 296,000,000 | 3.50% | 0.00% |
| Nov. 15, 2023 | AGILENT TECHNOLOGIES, INC. | $A | Raha Samraat S. | Sr. Vice President | F | Common Stock | 428 | $113.60 | 87,030.6096 | 296,000,000 | 0.49% | 0.00% |
| Nov. 14, 2023 | AGILENT TECHNOLOGIES, INC. | $A | Raha Samraat S. | Sr. Vice President | A | Common Stock | 11225 | $111.61 | 90,629.6096 | 296,000,000 | 14.14% | 0.00% |